US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Sparta Capital Ltd (PK) (SCAXF) 銘柄情報

Sparta Capital Ltd (PK) (SCAXF)

0.002

0.00

(0.00%)

終了 6月7日 5:00AM

Sparta Capital Ltd (PK) (SCAXF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.002

( - )

買値

0.002

売値

0.088

出来高

-

0.00 日の範囲 0.00

0.001 52 週間の範囲 0.09

時価総額

前日終値

0.002

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 0

発行済株式数

249,255,433

配当利回り

PER

-

1 株当たり利益 (EPS)

-

歳入

12.44M

純利益

134.63k

Sparta Capital Ltd. engages in environmental, energy, and health technologies businesses in Canada. It operates through Electronics Recycling and Safety Products Transactions segments. It engages in electronics recycling and reselling and product development in health care. The company was incorpora... Sparta Capital Ltd. engages in environmental, energy, and health technologies businesses in Canada. It operates through Electronics Recycling and Safety Products Transactions segments. It engages in electronics recycling and reselling and product development in health care. The company was incorporated in 1988 and is headquartered in Toronto, Canada. 詳細を表示

セクター

Industrials

業界

Industrial Goods

ウェブサイト

www.spartagroup.ca

本社

Toronto, Canada

設立

1988

Sparta Capital Ltd (PK) is listed in the Industrials sector of the その他OTC with ticker SCAXF. The last closing price for Sparta Capital (PK) was US$0. Over the last year, Sparta Capital (PK) shares have traded in a share price range of US$ 0.001 to US$ 0.09.

Sparta Capital (PK) currently has 249,255,433 shares in issue. The market capitalisation of Sparta Capital (PK) is US$498,510.87 .

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0.0007	53.8461538462	0.0013	0.002	0.0011	67430	0.00171628	CS
12	0.0007	53.8461538462	0.0013	0.002	0.0011	35225	0.00159068	CS
26	-0.008	-80	0.01	0.09	0.001	22417	0.00738104	CS
52	0.0009	81.8181818182	0.0011	0.09	0.001	71740	0.00944618	CS
156	-0.02	-90.9090909091	0.022	0.09	0.001	59417	0.01126872	CS
260	-0.0379	-94.9874686717	0.0399	0.09	0.001	49474	0.0158351	CS

SCAXF - Frequently Asked Questions (FAQ)

What is the current Sparta Capital Ltd (PK) share price?

The current share price of Sparta Capital Ltd (PK) is US$ 0.002

How many Sparta Capital Ltd (PK) shares are in issue?

Sparta Capital Ltd (PK) has 249,255,433 shares in issue

What is the market cap of Sparta Capital Ltd (PK)?

The market capitalisation of Sparta Capital Ltd (PK) is USD 498.51k

What is the 1 year trading range for Sparta Capital Ltd (PK) share price?

Sparta Capital Ltd (PK) has traded in the range of US$ 0.001 to US$ 0.09 during the past year

What is the registered address of Sparta Capital Ltd (PK)?

The registered address for Sparta Capital Ltd (PK) is 390 Bay Street, Toronto, Ontario, M5H 2Y2

What is the Sparta Capital Ltd (PK) website address?

The website address for Sparta Capital Ltd (PK) is www.spartagroup.ca

Which industry sector does Sparta Capital Ltd (PK) operate in?

Sparta Capital Ltd (PK) operates in the Industrial Goods sector

Zorax

And he, supposedly, is one of the "honest" ones, right? Honesty has never been in a otc chat board pumpers profile or vocabulary.
Facts are poison to otc shillers.

Flip it

Flip it 5分前

Read this

https://picmagazine.net/article/124178/Electro-optic_polymers_move_from_promise_to_production

EOT

Logical, but they have been doing this for years.

Years ago they mentioned many big brands wanting our Spider Silk. Without giving away names….Jon referenced the brands hanging in his closet. Of course they would all wait for the HOLY GRAIL.

It’s obvious we have a huge

One11

I was referring to Moon colonies, if you think Moon colonies are going to be regular everyday guys, I think you're wrong. Billionaires don't care about you or your family, by the way. For instance, take the amount of money that's going to be spent on data centers and then think about the amount of m

jour_trader

jour_trader 9分前

1.5-2B, but I would expect it to grow over time as well. Perhaps grows into $2.5B? No idea, but pricing pressures will be unlike anything we have seen before.

meixatech

meixatech 11分前

Folks,
IMO it is apparent to me that a major physiological benefit of some ampakines is the potential synergistic effect of combining with other bioactive molecules. Question posed to Google AI:

Would the molecules of the Neuroscience Research Group, Danube Neuroscience Resear

GoonOfWallSt

GoonOfWallSt 11分前

It's oddly quiet from the pumpsh!ts squad side. Did they all take a vacation for the whole month of June to celebrate their pride?

chemist72

chemist72 12分前

For some reason (which I don't understand), the Copilot links give different responses each time I click on them.
THEREFORE, PLEASE TAKE THESE RESULTS WITH CAUTION!! lol

I think Copilot may not be too good at complex math. Am going to try Google's AI with the same question.

janetcanada

janetcanada 13分前

☯️*** VSMT....& Positive Resumé Corroborate 🙌 By "Analyst Stock Titan"....
***https://www.stocktitan.net › news

☯️***From Barchart.....
***https://www.barchart.com/stocks/qu

chemist72

chemist72 17分前

Revised Copilot answer. LOL
https://www.bing.com/search?q=What+kind+of+growth+rate+is+required+to+go+from+%245M+in+revenues+to+%241B+in+revenues+over+3+years%2C+5+years+and+10+years%3F&form=ANNTH1&refig=6a25673c262b486cbd9f21ba447dd311&pc=EDGEDSE&adppc=EDGEBRV

M1Maggot

M1Maggot 18分前

I don't really care if they announce that they are selling the dirt on the property for topsoil but these clowns better come out with something that generates income or this stock will hit new lows and SOON !!!!!

jour_trader

jour_trader 18分前

Love seeing the movement on the Oxy patent dispute. We’ll still be held up by FDA even if case is dismissed.

upper11

upper11 21分前

77 19 24 11 Tia

meixatech

meixatech 22分前

The Neuroscience Research Group, Danube Neuroscience Research Laboratory focuses on the kynurenine pathway. According to AI:

The kynurenine pathway (KP) is the primary metabolic route for the essential amino acid tryptophan. It connects the immune, metabolic, and nervous syst

Golden Cross

Golden Cross 24分前

$ILLR 🗞️ Eight Sports Capital Secures Major Enic Stake
🔗 https://www.goal.com/en-gh/lists/tottenham-daniel-levy-sells-35-percent-enic-stake-eight-sports-capital/bltada9f5dccfa90152

(Triller $ILLR owns Eight Sports Capital)

✨ A new e

Golden Cross

Golden Cross 25分前

$ILLR 🗞️ Eight Sports Capital Secures Major Enic Stake
🔗 https://www.goal.com/en-gh/lists/tottenham-daniel-levy-sells-35-percent-enic-stake-eight-sports-capital/bltada9f5dccfa90152

(Triller $ILLR owns Eight Sports Capital)

✨ A new e

1kgwxman

1kgwxman 26分前

Sticks and stones...sticks and stones.
Smart investors ignore the "noise" and go about their lives.
Nobody controls or influences their investment decisions except themselves.
Anonymous attacks on specific stocks like AMFN are irrelevant and impotent, as are those against invest

Eagle1

Eagle1 26分前

Good Morning and Yes indeed SDCRBS, Great to see you here!

jimr1717

jimr1717 27分前

Bingo! It’s all a ruse! There is nothing here other than shares to dump on marks.

FrostyIsland3

FrostyIsland3 28分前

I read the article and have sympathy for the guy, but the article does not go into his treatment for GBM. He strikes me as the sort of person who has the wealth to afford DCVax-L and I hope he is trying this treatment because it will probably lengthen his life.

jour_trader

jour_trader 28分前

Today’s US market value is about $8B. So if you take 20% (go generic) of that you’re at $1.6B. Take another 20% of that for Elite’s potential market share, but again only about half (take 50% of that) would show up as revenue in our P&L due to splits. Quick back of envelope math gives me about $200M

chemist72

chemist72 29分前

Please draw your own conclusions.
I'm not trying to push one narrative over another.

trunkmonk

trunkmonk 33分前

now why would i base my financial decisions on a nobody in a utube vid? waste of time.

Sparta Capital (PK)

ProShares Short Financials

VanEck Israel ETF

Nanostring Technologies

Eastnine AB publ

0.981% until 05/14/47 0....

Energy Resources of Aust...

BlackRock Japan

iShares Global AAA AA Go...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。